To investigate the potential impact of IHCH9033 treatment on AML patients, we executed comparable gene expression analysis of these class I HDAC members between AML tumor and normal tissues, revealing that HDAC1, HDAC2 and HDAC3 were notably overexpressed in AML (Fig. 3f). The gene discussed is HDAC2; the disease is acute myeloid leukemia.